RSV Pre-F0 protein (FITC,His tag)

Produktnummer ABIN7488836

Recombinant RSV Pre-F0-Protein exprimiert in HEK-293 Cells.

Kurzübersicht für RSV Pre-F0 protein (FITC,His tag) (ABIN7488836)

Target: RSV Pre-F0

Protein-Typ: Recombinant

Spezies: Human respiratory syncytial virus A

Quelle: HEK-293 Cells

Reinheit: 90 %

Produktdetails

Aufreinigungstag / Konjugat: FITC,His tag

Verwendungszweck: FITC-Labeled Human respiratory syncytial virus A (strain A2) Pre-F0 Protein, His Tag

Sequenz: Gln 26- Leu 513

Produktmerkmale: FITC-Labeled Human respiratory syncytial virus A (strain A2) Pre-F0, His Tag is expressed from human 293 cells (HEK293). It contains AA Gln 26- Leu 513 (Accession # P03420).

Endotoxin-Niveau: 1.0 EU per μg

Anwendungsinformationen

Kommentare:

This protein carries a polyhistidine tag at the C-terminus. (FITC ,10xHis) The protein has a calculated MW of 56.1 kDa. The protein migrates as 60-65 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: PBS, pH 7.4

Lagerung: -20 °C

Informationen zur Lagerung: -20°C, avoid light

Antigendetails

Target: RSV Pre-F0

Hintergrund: Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation. Both states exhibit epitopes targeted by neutralizing antibodies, and post-fusion RSV F is being developed as a vaccine candidate.

Molekulargewicht: 56.1 kDa